Mental Health
01 Jan 2013
Duloxetine vs. active comparator in the treatment of patients with depression
How duloxetine compares to a medication currently available for the treatment of patients diagnosed with depression. Official Title Conditions – Depression Study Type Interventional Study Design Treatment Further Details Study Start Eligibility & Criteria Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both Criteria…
Mental Health
01 Jan 2013
Therapeutic Processes and Treatment Outcome in Adolescents with Anxiety Disorders
The purpose of this study is to examine the relationship between different aspects of cognitive behavior therapy (CBT) and treatment outcome. Official Title Process as a Predictor of Outcomes in CBT for Youth Conditions – Anxiety Disorders Study Type Interventional Study Design Treatment, Non-Randomized, Open Label, Active Control, Single…
Mental Health
01 Jan 2013
PUFA Augmentation in Treatment of Major Depression
The purpose of this study is to determine if omega-3 fatty acid EPA will enhance and speed up response to antidepressant therapy with Celexa (Citalopram) in people suffering from Major Depressive Disorder. All patients will receive Celexa, 50% will receive EPA, 50% placebo EPA. The purpose of this study is…
Mental Health
01 Jan 2013
Treatment Of Resistant Depression In Adolescents (TORDIA)
This is a study of depression in adolescents, ages 12 to 18, who are currently taking a prescribed selective serotonin reuptake inhibitor (SSRI) antidepressant medication but are still experiencing depression. The purpose of the study is to determine how best to treat adolescents with depression that is “resistant” to the…
Mental Health
01 Jan 2013
Preliminary Human Trial of NPI-028
This research will determine whether the Chinese herbal medicine (NPI-028) can make a significant contribution to the management of withdrawal and to follow-up treatment aimed at preventing or managing relapse in both women and men alcoholics. The herbal preparation has been used historically in the treatment of alcohol intoxication and…
Mental Health
01 Jan 2013
Glycine and D-Cycloserine in Schizophrenia
The purpose of this study is to compare the effects of D-cycloserine and glycine for treating negative symptoms (such as loss of interest, loss of energy, loss of warmth, and loss of humor) which occur between phases of positive symptoms (marked by hallucinations, delusions, and thought confusions) in schizophrenics. The…
Children's health
28 Dec 2012
Teen terminal illness blurs boundaries
Blurring professional and personal boundaries can sometimes happen when it comes to caring for adolescents and young adults (AYA) with a terminal illness, according to a Flinders University palliative care expert. Ms Kim Devery, a lecturer in the Department of Palliative and Supportive Services, and colleague Mrs Sharon…
Children's health
05 Dec 2012
Scientists identify depression and anxiety biomarker in youths
Scientists have discovered a cognitive biomarker – a biological indicator of a disease – for young adolescents who are at high risk of developing depression and anxiety. Their findings were published 28 November, in the journal PLOS ONE. The test for the unique cognitive biomarker, which can be done on…
Children's health
05 Dec 2012
Happy kids, happy future
At-risk children are more likely to successfully transition to secondary school if they take part in support programs during upper primary, a new study by ECU researchers has found. The project, entitled Happy Kids, was conducted by ECU researcher Professor Gary Partington in conjunction with the WA Department of Education…
